Related Experiment Videos
New macrolide antibiotics: clarithromycin and azithromycin.
1York Hospital, Pennsylvania.
American Family Physician
|September 1, 1992
Summary
Clarithromycin and azithromycin are novel macrolide antibiotics offering improved absorption and tissue penetration compared to erythromycin. These antibiotics are effective for respiratory and skin infections and show potential for treating opportunistic infections in immunocompromised patients.
Area of Science:
- Pharmacology
- Infectious Diseases
- Microbiology
Background:
- Clarithromycin and azithromycin are semisynthetic macrolide antibiotics.
- They are structurally related to erythromycin.
- These antibiotics offer improved pharmacokinetic and pharmacodynamic properties over erythromycin.
Purpose of the Study:
- To review the properties and applications of clarithromycin and azithromycin.
- To highlight their advantages over erythromycin.
- To discuss their potential in treating specific infections.
Main Methods:
- Literature review of existing studies on clarithromycin and azithromycin.
- Comparison of their spectrum of activity, absorption, distribution, and side effect profiles with erythromycin.
- Analysis of approved and potential clinical applications.
Main Results:
- Clarithromycin and azithromycin demonstrate excellent absorption and tissue penetration.
- They possess a broader spectrum of activity and reduced gastrointestinal side effects compared to erythromycin.
- Current FDA approvals include respiratory and skin infections.
Conclusions:
- Clarithromycin and azithromycin represent advancements in macrolide antibiotic therapy.
- Their efficacy extends to respiratory and skin infections.
- Potential utility in managing mycobacterial and Toxoplasma infections in acquired immunodeficiency syndrome (AIDS) patients warrants further investigation.